Pages that link to "Q36085208"
Jump to navigation
Jump to search
The following pages link to Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers (Q36085208):
Displaying 50 items.
- Abundant rodent furan-derived urinary metabolites are associated with tobacco smoke exposure in humans (Q24170376) (← links)
- The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex (Q24595571) (← links)
- Lung carcinogenesis by tobacco smoke (Q24625044) (← links)
- Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer (Q27692101) (← links)
- Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers (Q28396981) (← links)
- Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach (Q28662000) (← links)
- Biomarkers of Tobacco Exposure: Summary of an FDA-sponsored Public Workshop (Q29248704) (← links)
- Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. (Q30371072) (← links)
- Time to first cigarette predicts 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in adolescent regular and intermittent smokers, National Health and Nutrition and Examination Survey (NHANES) 2007-10. (Q33579037) (← links)
- Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort. (Q33614919) (← links)
- Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. (Q33909660) (← links)
- Public education about the relative harm of tobacco products: an intervention for tobacco control professionals (Q33990091) (← links)
- It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco. (Q34056291) (← links)
- Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats (Q34586229) (← links)
- Evidence supporting product standards for carcinogens in smokeless tobacco products (Q34987618) (← links)
- Combined analysis of the tobacco metabolites cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine (Q35044263) (← links)
- Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer (Q35164670) (← links)
- Predictors of the Nicotine Dependence Behavior Time to the First Cigarette in a Multiracial Cohort (Q35784902) (← links)
- Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer (Q35883271) (← links)
- Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers (Q36061132) (← links)
- Combined analysis of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users (Q36419992) (← links)
- Analysis of Tobacco-Specific Nitrosamines in the Common Smokeless Tobacco Afzal in Oman (Q36558268) (← links)
- Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling (Q36589155) (← links)
- Longitudinal study of [D10]phenanthrene metabolism by the diol epoxide pathway in smokers. (Q36623291) (← links)
- Nicotine reduction: strategic research plan (Q36823218) (← links)
- Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study (Q36828392) (← links)
- Simultaneous measurement of urinary total nicotine and cotinine as biomarkers of active and passive smoking among Japanese individuals (Q36832067) (← links)
- (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats (Q37151645) (← links)
- High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers (Q37243159) (← links)
- Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines. (Q37499926) (← links)
- Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study (Q37537563) (← links)
- Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai Cohort Study: remarkable coherence with rat tumor sites (Q37629435) (← links)
- Oral Cell DNA Adducts as Potential Biomarkers for Lung Cancer Susceptibility in Cigarette Smokers (Q37643215) (← links)
- Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample. (Q37705535) (← links)
- Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms (Q38514782) (← links)
- Tobacco toxicant exposure in cigarette smokers who use or do not use other tobacco products (Q38607385) (← links)
- Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma. (Q38774196) (← links)
- Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK. (Q39090703) (← links)
- CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study (Q40342867) (← links)
- Tobacco-specific N-nitrosamines and polycyclic aromatic hydrocarbons in cigarettes smoked by the participants of the Shanghai Cohort Study (Q40762115) (← links)
- Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study (Q41054488) (← links)
- Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes (Q47965250) (← links)
- NNK reduction pathway gene polymorphisms and risk of lung cancer. (Q48852585) (← links)
- Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop (Q49667007) (← links)
- Scientists seek new ways to prevent cancer: presenters at the American Society of Preventive Oncology annual meeting discuss biomarkers and trial design (Q51184929) (← links)
- Mechanisms of toxicity and biomarkers of flavoring and flavor enhancing chemicals in emerging tobacco and non-tobacco products. (Q52315865) (← links)
- Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)- (Q53176118) (← links)
- Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3) (Q56089362) (← links)
- Relationship of the oxidative damage biomarker 8-epi-prostaglandin F2α to risk of lung cancer development in the Shanghai Cohort Study (Q88568781) (← links)
- A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment (Q89464106) (← links)